Taysha Gene Therapies logo

Taysha Gene Therapies Share Price Today

(NASDAQ: TSHA)

Taysha Gene Therapies share price is $1.7 & ₹147.85 as on 6 Mar 2025, 2.30 'hrs' IST

$1.7

0.07

(4.29%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Taysha Gene Therapies share price in Dollar and Rupees. Guide to invest in Taysha Gene Therapies stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Taysha Gene Therapies, along with analyst recommendations, forecasts, and comprehensive financials.

Taysha Gene Therapies share price movements

  • Today's Low: $1.63
    Today's High: $1.74

    Day's Volatility :6.32%

  • 52 Weeks Low: $1.19
    52 Weeks High: $4.32

    52 Weeks Volatility :72.45%

Taysha Gene Therapies (TSHA) Returns

PeriodTaysha Gene Therapies IncSector (Health Care)Index (Russel 2000)
3 Months
-28.57%
3.7%
0.0%
6 Months
-19.43%
-2.8%
0.0%
1 Year
-37.27%
2.5%
0.0%
3 Years
-70.38%
12.9%
-11.6%

Taysha Gene Therapies (TSHA) Key Statistics

in dollars & INR

Previous Close
$1.63
Open
$1.64
Today's High
$1.74
Today's Low
$1.63
Market Capitalization
$334.2M
Today's Volume
$1.5M
52 Week High
$4.32
52 Week Low
$1.19
Revenue TTM
$8.3M
EBITDA
$-85.4M
Earnings Per Share (EPS)
$-0.36
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-121.94%

How to invest in Taysha Gene Therapies Stock (TSHA) from India?

It is very easy for Indian residents to invest directly in Taysha Gene Therapies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Taysha Gene Therapies stock in both Indian Rupees (INR) and US Dollars (USD). Search for Taysha Gene Therapies or TSHA on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Taysha Gene Therapies or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Taysha Gene Therapies shares which would translate to 0.512 fractional shares of Taysha Gene Therapies as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Taysha Gene Therapies, in just a few clicks!

Returns in Taysha Gene Therapies (TSHA) for Indian investors in Rupees

The Taysha Gene Therapies stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Taysha Gene Therapies investment value today

Current value as on today

₹67,679

Returns

₹32,321

(-32.32%)

Returns from Taysha Gene Therapies Stock

₹37,269 (-37.27%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Taysha Gene Therapies (TSHA)

10%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Taysha Gene Therapies Stock from India on INDmoney has increased by 10% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Taysha Gene Therapies

  • venBio Select Advisor LLC

    9.76%

  • Morgan Stanley - Brokerage Accounts

    8.61%

  • FMR Inc

    7.98%

  • BlackRock Inc

    6.60%

  • RA Capital Management, LLC

    5.30%

  • Octagon Capital Advisors LP

    5.10%

Analyst Recommendation on Taysha Gene Therapies

Buy

    87%Buy

    12%Hold

    0%Sell

Based on 16 Wall street analysts offering stock ratings for Taysha Gene Therapies(by analysts ranked 0 to 5 stars)

Based on 16 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
13
13
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Taysha Gene Therapies Stock (TSHA)

What analysts predicted

Upside of 287.7%

Target:

$6.59

Current:

$1.70

Insights on Taysha Gene Therapies Stock (Ticker Symbol: TSHA)

  • Price Movement

    In the last 7 days, TSHA stock has moved up by 6.9%
  • TSHA vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 103.8%
  • TSHA vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 121.9%
  • Price to Sales

    ForTSHA every $1 of sales, investors are willing to pay $51.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Taysha Gene Therapies Technicals Summary

Sell

Neutral

Buy

Taysha Gene Therapies is currently in a neutral trading position according to technical analysis indicators.

Taysha Gene Therapies (TSHA) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Taysha Gene Therapies Inc logo
8.28%
-19.43%
-37.27%
-70.38%
-92.93%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Taysha Gene Therapies Inc logo
2.7
NA
NA
-0.38
-1.22
-0.33
NA
0.35
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Taysha Gene Therapies Inc logo
Buy
$334.2M
-92.93%
2.7
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Taysha Gene Therapies

Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for the treatment of CLN7 disease; TSHA-118 for the treatment of CLN1 disease; TSHA-105 for the treatment of for SLC13A5 deficiency; TSHA-113 for the treatment of tauopathies; TSHA-106 for the treatment of angelman syndrome; TSHA-114 for the treatment of fragile X syndrome; and TSHA-101 for the treatment of GM2 gangliosidosis. Taysha Gene Therapies, Inc. has a strategic partnership with The University of Texas Southwestern Medical Center. Taysha Gene Therapies, Inc. was incorporated in 2019 and is headquartered in Dallas, Texas.
Organization
Taysha Gene Therapies
Employees
73
CEO
Mr. Sean P. Nolan
Industry
Health Technology

Management People of Taysha Gene Therapies

NameTitle
Mr. Sean P. Nolan
CEO & Chairman
Dr. Sukumar Nagendran M.D.
President, Head of Research & Development and Director
Mr. Kamran Alam CPA, M.B.A.
CFO & Corporate Secretary
Hayleigh Collins
Director of Corporate Communications & Investor Relations
Ms. Tracy M. Porter SPHR
Chief People Officer
Mr. Frederick Porter Ph.D.
Chief of Staff & Technical Operations Officer
Ms. Emily McGinnis M.P.H.
Chief Patient & External Affairs Officer and Endpoint & Outcome Development Lead
Mr. Sean McAuliffe
Chief Business Officer
Dr. Steven Gray Ph.D.
Chief Scientific Advisor of UT Southwestern Gene Therapy Program
Berge Minassian M.D.
Chief Medical Advisor of UT Southwestern Gene Therapy Program

Important FAQs about investing in TSHA Stock from India :

What is Taysha Gene Therapies share price today?

Taysha Gene Therapies share price today stands at $1.70, Open: $1.64 ; Previous Close: $1.63 ; High: $1.74 ; Low: $1.63 ; 52 Week High: $4.32 ; 52 Week Low: $1.19.

The stock opens at $1.64, after a previous close of $1.63. The stock reached a daily high of $1.74 and a low of $1.63, with a 52-week high of $4.32 and a 52-week low of $1.19.

Can Indians buy Taysha Gene Therapies shares?

Yes, Indians can invest in the Taysha Gene Therapies (TSHA) from India.

With INDmoney, you can buy Taysha Gene Therapies at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Taysha Gene Therapies at zero transaction cost.

How can I buy Taysha Gene Therapies shares from India?

It is very easy to buy Taysha Gene Therapies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Taysha Gene Therapies (TSHA) be purchased?

Yes, you can buy fractional shares of Taysha Gene Therapies with INDmoney app.

What are the documents required to start investing in Taysha Gene Therapies stocks?

To start investing in Taysha Gene Therapies, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Taysha Gene Therapies Stock (TSHA)?

Today’s highest price of Taysha Gene Therapies (TSHA) is $1.74.

Today’s lowest price of Taysha Gene Therapies (TSHA) is $1.63.

What is today's market capitalisation of Taysha Gene Therapies?

Today's market capitalisation of Taysha Gene Therapies TSHA is 334.2M

What is the 52 Week High and Low Range of Taysha Gene Therapies Stock (TSHA)?

  • 52 Week High

    $4.32

  • 52 Week Low

    $1.19

What are the historical returns of Taysha Gene Therapies (TSHA)?

  • 1 Month Returns

    8.28%

  • 3 Months Returns

    -19.43%

  • 1 Year Returns

    -37.27%

  • 5 Years Returns

    -92.93%

Who is the Chief Executive Officer (CEO) of Taysha Gene Therapies ?

Mr. Sean P. Nolan is the current Chief Executive Officer (CEO) of Taysha Gene Therapies.